Chemical Compound

4-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,6s)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one; 1-hexyl-3,7-dimethyl-purine-2,6-dione; nicotinic acid

CAS Registry Number 61216-25-9
4-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,6s)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one; 1-hexyl-3,7-dimethyl-purine-2,6-dione; nicotinic acid 结构式
Primary record

4-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,6s)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one; 1-hexyl-3,7-dimethyl-purine-2,6-dione; nicotinic acid

库存
8,580 克
纯度
98.3 %
CAS
61216-25-9

化合物标识与属性

CAS
61216-25-9
PubChem CID
194122
SMILES
CCCCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C.C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)OC3[C@@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O.C1=CC(=CN=C1)C(=O)O
Canonical SMILES
CCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O.C[C@@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)C1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O)[C@@H](C)O2)[C@@H](C)O1.O=C(O)c1cccnc1

名称与同义词

  • Card-cosaldon
  • AC1L4XMW
  • AC1Q5UAZ
  • CTK8D5284
  • AR-1F9156
  • CID194122
  • Digoxin mixture with Niacin and Pentifylline
  • 61216-25-9
  • 66523-11-3
  • 4-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,6s)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2
  • 4-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,6s)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one; 1-hexyl-3,7-dimethyl-purine-2,6-dione; nicotinic acid
  • (3beta,5beta,12beta)-3-((O-2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide mixt. with 1-hexyl-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione and 3-pyridinecarboxylic acid
  • 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,6S)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; 1-hexyl-3,7-dimethylpurine-2,6-dione; pyridine-3-carboxylic acid
  • 4-[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-3-[(2S,4S,6S)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tet